CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

BCR::ABL1 T315I — resistance to TKIs

Gene: BCR::ABL1 · Type: mutation

Indications: Chronic myeloid leukemia

SensitivityResistanceCIViC Context

FDA Resistance Assertions

DrugIndicationRecommendationFDA SourceLink
ImatinibChronic myeloid leukemiaNOT RECOMMENDED
FDA Label
Label
DasatinibChronic myeloid leukemiaNOT RECOMMENDED
FDA Label
Label
NilotinibChronic myeloid leukemiaNOT RECOMMENDED
FDA Label
Label